Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Show More...

  • Website https://www.madrigalpharma.com
  • Sector Healthcare
  • Industry Biotechnology
  • Last Quote 275.26 USD
  • Last Updated 30-05-2025
  • External Links Yahoo Finance Morningstar Ratios
  •   2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM
    Earnings Per Share USD -32.55 -35.0 -37.1 -44.45 -30.45 -40.03 -5.07 -2.54 -2.22 -5.45 -6.81
    Dividends USD
    Payout Ratio % *
    Shares Mil 1.0 1.0 2.0 2.0 3.0 5.0 12.0 15.0 15.0 15.0
    Book Value Per Share * USD 19.52 17.37 38.12 6.0 26.86 15.34 3.15 3.82 31.34 28.54 24.98
    Free Cash Flow Per Share * USD -33.24 -37.88 -32.19 -37.34 -25.25 -20.6 -8.35 -1.82 -1.79 -2.32
    Return on Assets % -72.77 -98.31 -86.4 -91.0 -87.97 -81.33 -48.24 -26.68 -9.68 -18.1 -23.57
    Financial Leverage (Average) 2.3 2.86 1.37 1.94 1.55 1.35 1.13 1.06 1.02 1.06 1.07
    Return on Equity % -154.85 -247.72 -139.78 -145.29 -150.86 -118.87 -60.79 -28.49 -9.95 -18.79 -24.59
    Return on Invested Capital % -119.01 -138.08 -102.52 -109.48 -110.8 -104.46 -58.11 -29.0 -12.28 -21.23 -26.85
    Interest Coverage -64.85 -23.32 -32.96 -33.25 -37.99 -63.72 -20.76
    Current Ratio 3.08 2.66 4.32 2.86 3.22 3.81 8.59 19.1 57.46 17.52 15.93
    Quick Ratio 3.05 2.62 4.28 2.84 3.16 3.74 8.44 19.05 57.29 17.47 15.89
    Debt/Equity 0.49 0.84 0.06 0.28 0.07